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Abstract
This study aimed to estimate prevalence of thy-
roid disorders in the São Paulo Ageing & Health 
Study, an epidemiological study addressing sev-
eral health-adverse outcomes among elderly 
people living in a poor area of São Paulo, Brazil. 
All participants answered a questionnaire and 
had a blood sample collected to assess levels of 
tireotropic hormone and free-thyroxine. Among 
1,373 people (60.8% women), prevalence rates 
(95% confidence interval) for thyroid dysfunction 
(%) were: overt hyperthyroidism, 0.7% (0.2-1.1)
[women: 0.8% (0.2-1.5); men: 0.4% (0.01-0.9)]; 
overt hypothyroidism, 5.7% (4.5-6.9) [women: 
5.9% (4.3-7.5); men: 5.4% (3.5-7.3)]; subclinical 
hyperthyroidism, 2.4% (1.6-3.2) [women: 2.8% 
(1.6-3.9); men: 1.9% (0.7-3.0)]; and subclinical hy-
pothyroidism, 6.5% (5.2-7.8) [women: 6.7% (5.0-
8.4); men: 6.1% (4.1-8.2)]. There was no differ-
ence in prevalence rates according to gender, but 
almost 40% of women were diagnosed and under 
treatment compared to 9% of men. The burden of 
thyroid disorders in this sample is high and most 
participants were not aware of them.
Thyroid Diseases; Aged; Hyperthyroidism; Hypo-
thyroidism
Introduction
Thyroid diseases are frequent in older individu-
als, and symptoms of hypothyroidism such as 
tiredness, fatigue, lack of concentration or dry 
skin can be very similar to complaints associat-
ed to ageing 1,2. Even for hyperthyroidism, clini-
cal presentation in elderly people is much more 
silent when compared to middle-aged people 3.
Beyond symptoms associated with thyroid dis-
orders, epidemiologic studies have shown a 
possible association between subclinical and 
overt thyroid disorders and cardiovascular dis-
ease 3,4,5,6.
A review published by the American College 
of Physicians estimated for population studies 
a pooled prevalence of overt hypothyroidism in 
women ≥ 70 years of 2% and in men ≥ 60 years 
of 0.8%. For overt hyperthyroidism, the num-
bers were 0.6% for women ≥ 60 years and 0.1% 
for men ≥ 60 years 7. Based on these data, some 
authors 8,9, have recommended screening for 
thyroid disorders especially in elderly people 
but this is not the view expressed in position 
papers from both the US Preventive Services 
Task Force 10 and the Canadian Task Force 11.
However, among older people with unspeci-
fied complaints, to rule out thyroid dysfunction 
is always a dilemma considering that only one 
third of cases show typical signs and symptoms 
of the disease, and treatment is cost effective 12.
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The present study addresses the prevalence 
of thyroid disorders in a population-based sam-
ple of low-income elderly people living in São 
Paulo, Brazil.
Methods
A cross-sectional population-based study was 
carried out with residents of an economically de-
prived area of São Paulo. Participants were those 
enrolled in the baseline assessment of the São 
Paulo Ageing & Health Study whose methodology 
can be assessed elsewhere 13,14.
Sample
The baseline assessment of the São Paulo Ageing 
& Health Study was carried out among all people 
aged 65 years or older who are residents in 66 
pre-determined census sectors (catchment ar-
eas) in the area of Butantan, a neighborhood lo-
cated on the Western side of São Paulo city. Study 
participants lived in shantytowns (“favelas”), or 
households covered by the Family Health Pro-
gram, with the lowest family income in the area. 
A total of 2,072 persons (91.4% of those invited) 
were recruited through systematic door knock-
ing and were included in the São Paulo Ageing & 
Health Study 1,15. As the investigation of thyroid 
disorders started after the baseline assessment of 
the São Paulo Ageing & Health Study was under-
way, 699 (33.7%) participants included in the São 
Paulo Ageing & Health Study with no data about 
thyroid function were excluded from the pres-
ent study. As such, 1,373 people had their blood 
sample collected to assess levels of thyroid stimu-
lating hormone (TSH) and free-thyroxin (F-T4) 
and were included in the study. Anti-thyroperox-
idase antibodies were evaluated in a random sub 
sample of 545 participants including men and 
women. There was no statistically significant dif-
ference between the alleatory subsample of el-
derly people submitted to anti-thyroperoxidase 
antibodies assessment compared to the others 
regarding proportion of women (respectively, 
63.6 vs. 59.7, p = 0.34), age [73 years (6.6) vs. 71.9 
(6.5), p = 0.27], body-mass index [25.5 kg/m2 (4.4) 
vs. 26.2 (4.7), p = 0.35], age-strata (p = 0.67), and 
school-years (p = 0.14).
Procedures
The study was conducted over a two-year peri-
od, from May 2003 to April 2005. A group of in-
terviewers trained to work in the present study 
carried out recruitment and interviewing of the 
participants. All those aged 65 years or over liv-
ing in the study catchment area who accepted 
to participate in the study were interviewed. 
This meant that in households with two or more 
elderly people, all of them were invited to par-
ticipate. All participants were assessed for socio-
economic characteristics.
A venous blood sample was obtained af-
ter an overnight fast. The serum obtained after 
centrifugation was used for hormone and bio-
chemistry measurements. TSH concentration 
(reference range 0.45-4.5mIU/L) was measured 
by immunometric assay (kit AutoDelfiahTSH; 
Perkinelmer Wallac Inc., Waltham, USA) and 
F-T4 concentration (reference range 0.6-1.8ng/
dL) was also determined using an immunomet-
ric assay (kit AutoDelfia T4; Perkinelmer Wallac 
Inc. Waltham Massachussets, USA). Anti-thyroid 
peroxidase (Tpoab) antibodies concentration 
(reference range < 35IU/mL) was measured by 
radioimmunoassay, using kit TpoAb RIA C.T. (BC 
1018; Biocode SA, Liège, Belgium).
Thyroid dysfunction was assessed using TSH 
and F-T4 as well as routine use of thyroid hor-
mones or antithyroid medications. There were 
no cases of hypothyroidism post thyroidectomy 
in this sample. Cut-off levels for TSH were < 
0.4IU/dL for hyperthyroidism and > 5.0IU/dL for 
hypothyroidism. Cut-off levels for F-T4 were < 
0.8ng/mL for hypothyroidism and > 1.8 for hy-
perthyroidism. People in the sample were classi-
fied in five categories for both hormones: clinical 
hyperthyroidism (low serum TSH combined with 
high levels of F-T4), subclinical hyperthyroidism 
(low serum TSH with normal levels of F-T4), eu-
thyroidism (normal TSH and normal F-T4), sub-
clinical hypothyroidism (high TSH with normal 
F-T4) and clinical hypothyroidism (high TSH 
combined with low levels of F-T4).
Age was classified in four strata: 65-69, 70-74, 
75-79 and ≥ 80 years old. Education was classified 
according to number of school-years in three cat-
egories: none, 1 to 3, and ≥ 4 years. Birth location 
was classified by country, state and city where 
each individual was born as well as the number 
of years they lived in areas of borderline iodine 
intake, the age each person arrived in São Paulo 
and how many years he/she has lived in the city 
of São Paulo since then. The interviewer evalu-
ated the use of prescription and over-the-counter 
medicines at home. He/she also checked dosage 
and interval time of administration of regular 
medical treatments, including medicines for hy-
perthyroidism or hypothyroidism.
Data analysis
Data entry was carried out twice using the Epi-
data 3.0 program (Epidata Assoc., Odense, Den-
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mark), and the validity check was carried out to 
identify and correct data entry errors. Data was 
analyzed using SPSS 15.0 (SPSS Inc., Chicago, 
USA). Prevalence of thyroid disease rates are pre-
sented as the number of cases per 100 persons. 
Ninety-five percent confidence intervals were 
also presented for prevalence. Chi-square tests 
were used for comparison when appropriate. 
Chi-square for linear trend analysis was used to 
measure the age effects of thyroid disease preva-
lence. A p value less than 0.05 was considered 
statistically significant.
Ethics
The study was approved by the Institutional 
Review Board and all participants signed an in-
formed consent form, according to the Declara-
tion of Helsinki. 
Results
Mean values of TSH were, for women and men 
respectively, 2.9 (5.4) mIU/mL and 2.9 (5.3) mIU/
mL; median values were 1.8 (1.1-2.9) mIU/mL in 
women and 1.8 (1.1-3.0) mIU/mL in men. Mini-
mum and maximum values were respectively 0.0 
and 94.0mIU/mL in women and 0.0 and 99.9mIU/
mL in men. Mean values of F-T4 were respectively 
for women and men 1.0 (0.2) ng/dL and 1.1 (0.7) 
ng/dL; median values were of 1.8 (1.1-2.9) ng/dL 
being exactly the same in women and men. Mini-
mum and maximum values were 0.01ng/dL and 
2.6ng/dL in women and 0.0ng/dL and 99.9ng/
dL in men.
Table 1 shows general characteristics of men 
and women in the sample according to thyroid 
function. No difference was found regarding 
these characteristics according to thyroid func-
tion. Table 2 shows prevalence of subclinical and 
clinical thyroid disease according to gender. We 
did not find any difference in the prevalence of 
clinical and subclinical thyroid diseases accord-
ing to gender.
Table 3 shows the prevalence of thyroid dis-
ease by age range and gender. Frequency of thy-
roid disorders for both sexes did not change sig-
nificantly according to age range, although the 
frequency of overt hyperthyroidism in men was 
too small to allow for any conclusions. The pro-
portion of participants who grew up in an area of 
iodine deficiency was different between the gen-
ders: 80.8% of women and 85.3% of men raised 
in an area of low iodine intake during infanthood 
(p = 0.04).
Of the seven women with overt hyperthyroid-
ism, three (42.9%) were under treatment. Of the 
two men in the same condition, one (50%) was 
also under treatment. Of these four people, all 
have normal levels of TSH, suggesting good con-
trol. Of the 56 women with overt hypothyroid-
ism, 21 (38.2%) were under treatment. For the 
33 men in the same condition, only three (9.1%) 
were under treatment. Of all 24 hypothyroid peo-
ple under treatment, all the men and 17 (81%) 
of the women were under control; three (14.2%) 
women were partially controlled (subclinical hy-
pothyroidism) and one was out of control (high 
levels of TSH combined with low F-T4 levels). The 
difference in the prevalence of hypothyroidismin 
women compared to men was statistically sig-
nificant (p = 0.006) showing a high number of 
diagnoses in women compared to men.
Prevalence of anti-thyroperoxidase antibod-
ies was of 10.7% in women and 9.2% in men with 
no difference between them (p = 0.34). There 
was no difference in the prevalence of anti-thy-
roperoxidase antibodies according to age-stra-
ta for men, women or both together (data not 
showed).
Discussion
In this sample of older men and women, preva-
lence rates of overt hyperthyroidism were 0.8% 
in women and 0.4% in men; for hypothyroidism, 
prevalence was 5.9% in women and 5.4% in men. 
Regarding subclinical thyroid diseases, preva-
lence of subclinical hyperthyroidism was 2.8% 
in women and 1.9% in men; and for subclinical 
hypothyroidism, prevalence in women was 6.7% 
and in men was 6.1%. There was no difference in 
the prevalence rates of thyroid diseases accord-
ing to gender.
Regarding diagnosis and control, of all the 
women with overt thyroid disease, 38.7% had 
been diagnosed and were under control, corre-
sponding to 42.8% of hyperthyroid women and 
38.2% of hypothyroid women. For men with 
overt thyroid disease, 11.4% had been diagnosed 
and were under control, corresponding to 50% 
of hyperthyroid men, and only 9.1% of hypothy-
roid men. Data suggest that there is a gender bias 
in diagnosis of hypothyroidism in this sample of 
older men and women.
Comparing our data with similar data from 
other studies using the same cut-off, frequency 
of hypothyroidism in this sample is higher than 
the pooled prevalence of hypothyroidism in 
population-based studies of 2% in women aged 
70 to 80; and of 1% in women and 0.7% in men 
aged over 60 7. However, these data are similar to 
data results from the Colorado Thyroid Disease 
Prevalence Study in which 16% of women and 
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Table 1
Characteristics of participants according to thyroid status.
Characteristics Overt 
hyperthyroidism 
(n = 9)
Subclinical 
hyperthyroidism 
(n = 33)
Normal 
function 
(n = 1,164)
Subclinical 
hypothyroidism 
(n = 89)
Overt 
hypothyroidism 
(n = 78)
Proportion of female (%) 7 (77.8) 23 (69.7) 700 (60.1) 56 (62.9) 49 (62.8)
Mean age and standard 
deviation [years]
70.8 (4.3) 71.2 (6.2) 72.1 (6.3) 72.4 (6.7) 71.3 (5.6)
Age-strata [years] (%)     
65-69 4 (0.7) 16 (2.7) 503 (84.3) 38 (6.4) 36(6.0)
70-74 3 (0.8) 9 (2.4) 319 (83.9) 23 (6.1) 26 (6.8)
75-79 2 (0.9) 6 (2.7) 190 (86.4) 14 (6.4) 8 (3.6)
≥ 80 0 (0,0) 2 (1.1) 152 (86.4) 14 (8.0) 8 (4.5)
School-years (%)
Illiterate 2 (0.4) 10 (1.8) 471 (85.2) 41 (7.4) 29 (5.2)
1-4 7 (1.0) 21 (3.0) 582 (83.7) 40 (5.8) 45 (6.5)
> 4.0 0 (0.0) 1 (0.8) 108 (89.3) 8 (6.6) 4 (3.3)
Born/raised in goiter-area (%) 7 (77.8) 30 (90.9) 956 (83.5) 74 (86.0) 62 (81.6)
Table 2
Prevalence (%; and 95% confi dence interval) of thyroid dysfunctions in older people according to gender.
Thyroid dysfunctions All (N = 1,373) Men (n = 538) Women (n = 835) p-value
n % n % n %
Subclinical hyperthyroidism 33 2.4 (1.6-3.2) 10 1.9 (0.7-3.0) 23 2.8 (1.6-3.9) 0.61
Overt hyperthyroidism 9 0.7 (0.2-1.1) 2 0.4 (0.01-0.9) 7 0.8 (0.2-1.5)
Subclinical hypothyroidism 89 6.5 (5.2-7.8) 33 6.1 (4.1-8.2) 56 6.7 (5.0-8.4)
Overt hypothyroidism 78 5.7 (4.5-6.9) 29 5.4 (3.5-7.3) 49 5.9 (4.3-7.5)
11% of men between 65 and 74 years old had a 
TSH higher than 5.0IU/L compared to 12.6% of 
women and 11.5% of men in the present study 16. 
Parle et al. 6 found a prevalence of hypothyroid-
ism in a population-based sample of people over 
60 of 8.3% considering both men and women 
compared to 5.7% in the present study. Recently, 
Gussekloo et al. 17 found a prevalence of subclini-
cal hypothyroidism in 5.1% and of overt hypothy-
roidism in 1.2% in 588 individuals of both gender 
over the age of 85. In comparison with the Colo-
rado Prevalence Study, the frequency of thyroid 
disease is very similar for men and women in São 
Paulo 16.
Regarding hyperthyroidism, a review of sev-
eral previous studies gave a pooled prevalence of 
0.7% in women over 60 7. In a recent study by Gus-
sekloo et al. 17 with a sample of men and women, 
prevalence of overt hyperthyroidism was 0.3% 
and of subclinical hyperthyroidism was 2.9%, 
very similar to 2.4% for subclinical and 0.7% for 
overt disease in our sample.
Diagnosis of previous overt hypothyroidism 
in this sample was carried out with more fre-
quency in women than in men (p = 0.006). We 
can speculate that, first, women look for medical 
treatment more frequently than do men 16,17,18,19. 
Second, it is possible that there is some kind of 
gender bias. As thyroid disease is more frequent 
in women than in men, physicians screen thyroid 
function in elderly women more frequently com-
pared to men 20,21.
Frequency of thyroid disorders in this sam-
ple did not change according to age-strata. In 
the Colorado study, prevalence of an elevated 
TSH increased with age for men and women 16.
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Table 3
Prevalence of thyroid disease by gender according to age-strata.
Age-strata (years) p-value
65-69 70-74 75-79 ≥ 80
All [N =1,373 (100%)] 597(43.5) 380 (27.7) 220 (16.0) 176(12.8) 0.87
Subclinical hyperthyroidism 16 (2.7) 9 (2.4) 6 (2.7) 2 (1.1)
Overt hyperthyroidism 4 (0.7) 3 (0.8) 2 (0.9) 0
Subclinical hypothyroidism 38 (6.4) 23 (6.1) 14 (6,4) 14 (8,0)
Overt hypothyroidism 36 (6.0) 26 (6.8) 8 (3.6) 8 (4.5)
Men [n = 538 (100%)] 247 (45.9) 147 (27.3) 80 (14.9) 64 (11.9) 0.43
Subclinical hyperthyroidism 4 (1.6) 2 (1.4) 3 (3.8) 1 (1.6)
Overt hyperthyroidism 1 (0.4) - 1 (1.3) -
Subclinical hypothyroidism 14 (5.7) 9 (6.1) 7 (8.8) 3 (4.7)
Overt hypothyroidism 13 (5.3) 13 (8.8) 1 (1.3) 2 (3.1)
Women [n = 835 (100%)] 350 (41.9) 233 (27.9) 140 (16.8) 112 (13.4) 0.86
Subclinical hyperthyroidism 12 (3.4) 7 (3.0) 3 (2.1) 1 (0.9)
Overt hyperthyroidism 3 (0.9) 3 (1.3) 1 (0.7) -
Subclinical hypothyroidism 24 (6.9) 14 (6.0) 7 (5.0) 11 (9.8)
Overt hypothyroidism 23 (6.6) 13 (5.6) 7 (5.0) 6 (5.4)
Hollowell et al. 22 have also found similar re-
sults. However, data from Parle et al. 6, in 1,193 
patients, showed a stable prevalence of elevated 
TSH concentration in men and women over the 
age of 60, as did Sawin et al. 1 using data from 
the Framingham Study. Andersen-Ranberg et 
al. 15, studying centenarians concluded that thy-
roid dysfunction did not seem more prevalent 
among centenarians than among young old peo-
ple. Another possibility is that the results may 
have been subject to bias due to the small num-
ber of people over 70 in our sample, caused by a 
higher rate of cardiovascular disease mortality in 
a very low-income sample.
In this sample of ageing people, anti-thy-
roperoxidase antibodies were constant and did 
not change according to age. Data from the Na-
tional Health and Nutrition Examination Sur-
vey (NHANES III) showed a prevalence of anti-
thyroperoxidase antibodies that increases with 
age in both men and women 22. Again, the small 
number of people aged over 70 could be an ex-
planation for this result.
Prevalence of thyroid disease in this sample 
is almost the same for men and women with a 
women/men ratio of 1.1 for overt hypothyroid-
ism and of 1.2 for all thyroid disease. These data 
could be explained by the fact that more men than 
women in this sample were born and grew up in 
areas of low iodine intake (80.3% in women vs. 
85.3% in men, p = 0.004). Although we now have 
some data from other studies showing a more 
than adequate iodine uptake in Brazil especially 
after 1996, we did not evaluate iodine intake in 
our sample 1,22.
Concluding, our results showed a prevalence 
of thyroid disease in women similar to other 
countries. However, prevalence of thyroid dis-
ease in men is higher than results in other coun-
tries with a women/men ratio of 1.2 for all thy-
roid disease and for overt hypothyroidism, with 
most men with hypothyroidism in this sample 
being undiagnosed.
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Resumo
O objetivo da pesquisa foi avaliar a prevalência de do-
enças da tireóide no São Paulo Ageing & Health Study, 
estudo epidemiológico focado em desfechos de saú-
de adversos em amostra de idosos moradores de São 
Paulo, Brasil. Todos os participantes responderam a 
questionário e colheram sangue para dosagem de hor-
mônio tireotrópico e tiroxina-livre. Entre os 1.373 par-
ticipantes (60,8% mulheres), a prevalência (intervalo 
de 95% de confiança) de hipertireoidismo clínico foi 
de 0,7% (0.2-1,1) [mulheres: 0,8% (0,2-1,5); homens: 
0,4% (0,01-0,9)]; hipotireoidismo clínico, 5,7% (4,5-
6,9) [mulheres: 5,9% (4,3-7,5); homens: 5,4% (3,5-7,3)]; 
hipertireoidismo subclínico, 2,4% (1,6-3,2) [mulheres: 
2,8% (1,6-3,9); homens: 1,9% (0,7-3,0)]; e hipotireoi-
dismo subclínico, 6,5% (5,2-7,8) [mulheres: 6,7% (5,0-
8,4); homens: 6,1% (4,1-8,2)]. Não houve diferença na 
prevalência de doenças da tireóide por sexo. Quarenta 
por cento das mulheres tinham diagnóstico e estavam 
tratando, comparadas a 9% dos homens. A prevalência 
de disfunção tireoidiana foi elevada e a maioria dos 
participantes desconhecia o diagnóstico.
Doenças da Glândula Tireóide; Idoso; Hipertireoidis-
mo; Hipotireoidismo
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